NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPV
HTERT 在 HPV 细胞永生化中的非典型功能
基本信息
- 批准号:8685210
- 负责人:
- 金额:$ 19.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgingAgreementApoptosisApoptoticBindingBinding ProteinsBiologicalBiological AssayBypassCancer EtiologyCell AgingCell ProliferationCell divisionCellsCharacteristicsComplexDNADataDevelopmentEpigenetic ProcessEventGenesGeneticGenetic TranscriptionGoalsGrantGrowthHPV E7HPV-High RiskHomeostasisHumanHuman PapillomavirusInhibition of ApoptosisLaboratoriesLibrariesLow risk HPVMalignant NeoplasmsMalignant neoplasm of anusMalignant neoplasm of cervix uteriMediatingMethodsMultienzyme ComplexesMutationOncogenesOncogenicPaperPapillomavirusPharmaceutical PreparationsPlayPropertyProteinsRNA Recognition MotifRNA SplicingRNA-Directed DNA PolymeraseResearchResearch Project GrantsRoleStagingStem cellsTERT geneTelomeraseTelomere ShorteningTertiary Protein StructureTimeTransactivationTranscriptional ActivationUnited States National Institutes of HealthVariantViralVirusWorkcell immortalizationexpression vectorhuman TERT proteinimmortalized cellinsightkeratinocytemalignant mouth neoplasmmutantneoplastic celloverexpressionpathogenpreventprogramspromoterpublic health relevanceresponsetelomerase reverse transcriptasetelomeretherapeutic targettranscription factortumorubiquitin ligaseuncontrolled cell growth
项目摘要
DESCRIPTION (provided by applicant): Cell immortalization is a critical event in the development of cancer and the oncogenic human papillomaviruses encode an E6 oncogene that is primarily responsible for inducing telomerase activity and consequent immortalization. Recent studies indicate that the HPV E6 protein mediates the increase in telomerase activity via its ability to engage and activate the hTERT promoter and interact directly with at least two promoter-bound proteins, Myc and NFX-1. E6 also has a post-translational mechanism to increase telomerase activity by binding directly to hTERT proteins. In the current grant, we show that hTERT immortalization of primary keratinocytes is independent of its telomerase activity or ability to elongate telomeres. In agreement with recent work with stem cells, our new preliminary findings demonstrate that hTERT can alter the expression of keratinocyte genes as well as increase the expression of HPV genes. We hypothesize that the transcription activation function of hTERT or its potential role in altering apoptotic responses may play an essential role in bypassing the M1/M2 restriction points in cell proliferation and thereby facilitate cell immortalization. In this application, we will evaluate these possibilities using a library of mutan hTERT expression vectors. We will correlate the ability of these mutant proteins to efficiently bypass cellular senescence with their ability to induce reverse transcriptase activity, hTR binding, telomere binding, telomere elongation, promoter transactivation, and modulation of apoptosis. These studies will provide new insights into a basic event in the etiology of cancer.
描述(由申请人提供):细胞永生化是癌症发展的关键事件,致瘤性人乳头瘤病毒编码E6癌基因,该基因主要负责诱导端粒酶活性和随后的永生化。最近的研究表明,HPV E6蛋白通过其参与和激活hTERT启动子的能力介导端粒酶活性的增加,并直接与至少两种启动子结合蛋白Myc和NFX-1相互作用。E6还具有通过直接与hTERT蛋白结合来增加端粒酶活性的翻译后机制。在目前的研究中,我们发现原代角质形成细胞的hTERT永化独立于其端粒酶活性或延长端粒的能力。与最近的干细胞研究一致,我们新的初步发现表明,hTERT可以改变角质细胞基因的表达,并增加HPV基因的表达。我们假设hTERT的转录激活功能或其在改变凋亡反应中的潜在作用可能在细胞增殖中绕过M1/M2限制点从而促进细胞永生方面发挥重要作用。在本应用程序中,我们将使用一个可变hTERT表达向量库来评估这些可能性。我们将把这些突变蛋白有效绕过细胞衰老的能力与它们诱导逆转录酶活性、hTR结合、端粒结合、端粒延伸、启动子反激活和细胞凋亡调节的能力联系起来。这些研究将为癌症病因学中的一个基本事件提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuefeng Liu其他文献
Xuefeng Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuefeng Liu', 18)}}的其他基金
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men
开发功能性人体细胞模型来研究 AA 和 EA 男性前列腺癌的发生和进展
- 批准号:
10566633 - 财政年份:2023
- 资助金额:
$ 19.68万 - 项目类别:
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
尿癌细胞培养 (UCCC) 尿液样本分析前因素的评估——一种非侵入性生物标志物 — 用于监测膀胱癌的反应和复发
- 批准号:
10640606 - 财政年份:2023
- 资助金额:
$ 19.68万 - 项目类别:
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
在膀胱癌诊所中验证尿液衍生癌细胞 (UDCC)——非侵入性活体液体活检
- 批准号:
10395552 - 财政年份:2021
- 资助金额:
$ 19.68万 - 项目类别:
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
在膀胱癌诊所中验证尿液衍生癌细胞 (UDCC)——非侵入性活体液体活检
- 批准号:
10605346 - 财政年份:2021
- 资助金额:
$ 19.68万 - 项目类别:
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
去势抵抗性前列腺癌 (CRPC) 的条件重编程细胞模型
- 批准号:
10336637 - 财政年份:2019
- 资助金额:
$ 19.68万 - 项目类别:
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
去势抵抗性前列腺癌 (CRPC) 的条件重编程细胞模型
- 批准号:
10223223 - 财政年份:2019
- 资助金额:
$ 19.68万 - 项目类别:
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
去势抵抗性前列腺癌 (CRPC) 的条件重编程细胞模型
- 批准号:
10478023 - 财政年份:2019
- 资助金额:
$ 19.68万 - 项目类别:
NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPV
HTERT 在 HPV 细胞永生化中的非典型功能
- 批准号:
8568104 - 财政年份:2013
- 资助金额:
$ 19.68万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 19.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)